1. Yáñez ML, Miller JJ, Batchelor TT. Diagnosis and treatment of epidural metastases. Cancer 2017;7:1106-1114 DOI: 10.1002/cncr.30521
2. Ciftdemir M, Kaya M, Selcuk E, et al. Tumors of the spine. World J Orthop 2016;7:109-116 DOI: 10.5312/wjo.v7.i2.109
3. Bartels RH, van der Linden YM, van der Graaf WT. Spinal extradural metastasis: review of current treatment options. CA Cancer J Clin 2008;58:245–259 DOI: 10.3322/CA.2007.0016
4. Bollen L, van der Linden YM, Pondaag W, et al. Prognostic factors associated with survival in patients with symptomatic spinal bone metastases: a retrospective cohort study of 1,043 patients. Neuro Oncol 2014;16:991–998 DOI: 10.1093/neuonc/not318
5. Witham TF, Khavkin YA, Gallia GL, et al. Surgery insight: current management of epidural spinal cord compression from metastatic spine disease. Nat Clin Pract Neurol 2006;2:87–94 DOI: 10.1038/ncpneuro0116
6. Bartels RH, Feuth T, van der Maazen R, et al. Development of a model with which to predict the life expectancy of patients with spinal epidural metastasis. Cancer 2007;110:2042–2049 DOI: 10.1002/cncr.23002
7. Spratt DE, Beeler WH, de Moraes FY, et al. An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium report. Lancet Oncol 2017;18:e720–e730 DOI: 10.1016/S1470-2045(17)30612-5
8. Coleman RE. Metastatic bone disease: Clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 2001;27:165–176 DOI: 10.1053/ctrv.2000.0210
9. Coleman RE. Skeletal complications of malignancy. Cancer 1997;80:1588–1594 DOI: 10.1002/(sici)1097-0142(19971015)80:8+<1588::aid-cncr9>3.3.co;2-z
10. Plunkett TA, Rubens RD. The biology and management of bone metastases. Crit Rev Oncol Hematol 1999;31:89–96 DOI: 10.1016/s1040-8428(99)00008-6
11. Norgaard M, Jensen AO, Jacobsen JB, et al. Skeletal related events, bone metastasis and survival of prostate cancer: A population based cohort study in Denmark (1999 to 2007). J Urol 2010;184:162–167 DOI: 10.1016/j.juro.2010.03.034
12. Yong M, Jensen AO, Jacobsen JB, et al. Survival in breast cancer patients with bone metastases and skeletal-related events: A population-based cohort study in Denmark (1999–2007). Breast Cancer Res Treat. 2011;129:495–503 DOI: 10.1007/s10549-011-1475-5
13. Sathiakumar N, Delzell E, Morrisey MA, et al. Mortality following bone metastasis and skeletal-related events among men with prostate cancer: A population-based analysis of us medicare beneficiaries, 1999–2006. Prostate Cancer Prostatic Dis 2011;14:177–183. DOI: 10.1038/pcan.2011.7
14. Eda H, Santo L, David Roodman G, et al. Bone disease in multiple myeloma. Cancer Treat Res 2016;169:251-70 DOI: 10.1007/978-3-319-40320-5_14
15. Choi D, Crockard A, Bunger C, et al. Review of metastatic spine tumour classification and indications for surgery: the consensus statement of the Global Spine Tumour Study Group. Eur Spine J 2010;19:215–222. DOI: 10.1007/s00586-009-1252-x
16. Ibrahim A, Crockard A, Antonietti P, et al. Does spinal surgery improve the quality of life for those with extradural (spinal) osseous metastases? An international multicenter prospective observational study of 223 patients. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2007. J Neurosurg Spine 2008;8:271–278 DOI: 10.3171/SPI/2008/8/3/271
17. Tomita K, Kawahara N, Kobayashi T, et al. Surgical strategy for spinal metastases. Spine 2001;26:298–306 DOI: 10.1097/00007632-200102010-00016
18. Tokuhashi Y, Matsuzaki H, Oda H, et al. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine 2005;30:2186–2191 DOI: 10.1097/01.brs.0000180401.06919.a5
19. Hatrick NC, Lucas JD, Timothy AR, et al. The surgical treatment of metastatic disease of the spine. Radiother Oncol 2000;56:335–339 DOI: 10.1016/s0167-8140(00)00199-7
20. Hussein AA, El-Karef E, Hafez M. Reconstructive surgery in spinal tumours. Eur J Surg Oncol 2001;27:196–199 DOI: 10.1053/ejso.2000.1079
21.Hirabayashi H, Ebara S, Kinoshita T, et al. Clinical outcome and survival after palliative surgery for spinal metastases: palliative surgery in spinal metastases. Cancer 2003;97:476–484 DOI: 10.1002/cncr.11039
22. Weigel B, Maghsudi M, Neumann C, et al. Surgical management of symptomatic spinal metastases. Postoperative outcome and quality of life. Spine 1999;24:2240–2246 DOI: 10.1097/00007632-199911010-00012
23. Fujibayashi S, Neo M, Miyaki K, et al. The value of palliative surgery for metastatic spinal disease: satisfaction of patients and their families. Spine J 2010;1:42-49 DOI: 10.1016/j.spinee.2009.06.016
24. Wheatley-Price P, Ali M, Balchin K, Spencer J, et al. The role of palliative chemotherapy in hospitalized patients. Curr Oncol 2014;4:187–192 DOI: 10.3747/co.21.1989
25. Crosara TM, Marques DF, Ferrari AC, et al. The effects of palliative chemotherapy in metastatic colorectal cancer patients with an ECOG performance status of 3 and 4. Clin Colorectal Cancer 2015;1:52–57 DOI: 10.1016/j.clcc.2014.09.010
26. Peppercorn JM, Smith TJ, Helft PR, et al. American Society of Clinical Oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol 2011;6:755–760 DOI: 10.1200/JCO.2010.33.1744
27. Schnipper LE, Smith TJ, Raghavan D, et al. American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology. J Clin Oncol 2012;14:1715–1724 DOI: 10.1200/JCO.2012.42.8375
28. Smith TJ, Hillner BE. Bending the cost curve in cancer care. N Engl J Med 2011;364:2060–2065 DOI: 10.1056/NEJMsb1013826
29. Ahmad I, Ahmed MM, Ahsraf MF, et al. Pain Management in Metastatic Bone Disease: A Literature Review. Cureus 2018;9:e3286 DOI: 10.7759/cureus.3286
30. Matsumura A, Hoshi M, Takami M, et al. Radiation Therapy without Surgery for Spinal Metastases: Clinical Outcome and Prognostic Factors Analysis for Pain Control. Global Spine J 2012;3:137–142 DOI: 10.1055/s-0032-1326948
31. Hikata T, Isogai N, Shiono Y, et al. A Retrospective Cohort Study Comparing the Safety and Efficacy of Minimally Invasive Versus Open Surgical Techniques in the Treatment of Spinal Metastases. Clinical Spine Surgery 2017;8:E1082-87 DOI: 10.1097/BSD.0000000000000460
32. Maynard FM, Jr, Bracken MB, Creasey G, et al. International Standards for Neurological and Functional Classification of Spinal Cord Injury. American Spinal Injury Association. Spinal Cord 1997;35:266–274. DOI: 10.1038/sj.sc.3100432
33. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649–655
34. Fisher CG, DiPaola CP, Ryken TC, et al. A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine 2010;22:E1221-9 DOI: 10.1097/BRS.0b013e3181e16ae2
35. Katagiri H, Okada R, Takagi T, et al. New Prognostic factors and scoring system for patients with skeletal metastasis. Cancer Medicine 2014;5:1359-1367 DOI: 10.1002/cam4.292
36. McMillan DC. An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer: nutrition Society and BAPEN Medical Symposium on ‘Nutrition support in cancer therapy.’. Proc Nutr Soc 2008;67:257-262 DOI: 10.1017/S0029665108007131
37. Mohri Y, Inoue Y, Tanaka K, et al. Prognostic nutritional index predicts postoperative outcome in colorectal cancer. World J Surg 2013;37:2688–2692 DOI: 10.1007/s00268-013-2156-9
38. Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transpl 2013;48:452–458 DOI: 10.1038/bmt.2012.244
39. Kakutani K, Sakai Y, Maeno K, et al. Prospective Cohort Study of Performance Status and Activities of Daily Living After Surgery for Spinal Metastasis. Clin Spine Surg 2017;30:E1026-32 DOI: 10.1097/BSD.0000000000000456
40. Kanda Y, Kakutani K, Sakai Y, et al. Prospective cohort study of surgical outcome for spinal metastases in patients aged 70 years or older. Bone Joint J 2020;12:1709-1716 DOI: 10.1302/0301-620X.102B12.BJJ-2020-0566.R1
41. Yamashita T, Aota Y, Kushida K, et al. Changes in physical function after palliative surgery for metastatic spinal tumor: association of the revised Tokuhashi score with neurologic recovery. Spine 2008;21:2341-6 DOI: 10.1097/BRS.0b013e3181878733
42. Kobayashi K, Ando K, Nakashima H, et al. Prognostic Factors in the New Katagiri Scoring System after Palliative Surgery for Spinal Metastasis. Spine 2020;13:E813-E819 DOI: 10.1097/BRS.0000000000003415
43. Moon KY, Chung CK, Jahng TA, et al. Postoperative survival and ambulatory outcome in metastatic spinal tumors: prognostic factor analysis. J Korean Neurosurg Soc 2011;3:216-23 DOI: 10.3340/jkns.2011.50.3.216
44. Lindenmann J, Fink-Neuboeck N, Koesslbacher M, et al. The influence of elevated levels of C-reactive protein and hypoalbuminemia on survival in patients with advanced inoperable esophageal cancer undergoing palliative treatment: CRP and albumin in esophageal cancer. J Surg Oncol 2014;110:645-50 DOI: 10.1002/jso.23711
45. Vanhoutte G, van de Wiel M, Wouters K, et al. Cachexia in cancer: what is in the definition? BMJ Open Gastroenterol 2016;3:e000097 DOI: 10.1136/bmjgast-2016-000097
46. Douglas E, McMillan DC. Towards a simple objective framework for the investigation and treatment of cancer cachexia: the Glasgow Prognostic Score. Cancer Treat Rev 2014;40:685-91 DOI: 10.1016/j.ctrv.2013.11.007
47. Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011;12:489–95 DOI: 10.1016/S1470-2045(10)70218-7
48. Andreyev HJ, Norman AR, Oates J, et al. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 1998;34:503–509. DOI: 10.1016/s0959-8049(97)10090-9
49. Attaix D, Ventadour S, Codran A, et al. The ubiquitin-proteasome system and skeletal muscle wasting. Essays Biochem 2005;41:173–186 DOI: 10.1042/EB0410173
50. Prado CM, Baracos VE, McCargar LJ, et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patientsreceivingcapecitabine treatment. Clin Cancer Res 2009;15:2920–2926 DOI: 10.1158/1078-0432.CCR-08-2242
51. Argiles JM, Busquets S, Stemmler B, et al. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer 2014;14:754–762 DOI: 10.1038/nrc3829
52. Muscaritoli M, Bossola M, Aversa Z, et al. Prevention and treatment of cancer cachexia: new insights into an old problem. Eur J Cancer 2006;42:31–41 DOI: 10.1016/j.ejca.2005.07.026
53. Falicov A, Fisher CG, Sparkes MJ, et al. Impact of surgical intervention on quality of life in patients with spinal metastases. Spine.2006;24:2849–2856 DOI: 10.1097/01.brs.0000245838.37817.40